September 2026
The biosimilar monoclonal antibody market was valued at USD 19.73 billion in 2026, with leading companies including Roche, Mylan, Biogen.
July 2025
The global antibody therapy market size reached USD 313.47 billion in 2024 and is predicted to surpass around USD 973.60 billion by 2034, with a solid CAGR of 12%.
September 2026
The global combination antibody therapy market size is estimated to hit around USD 700.59 billion by 2035 increasing from USD 268.17 billion in 2026, with a CAGR of 11.26%.
September 2026
The global antibody purification service market size was evaluated at USD 3.31 billion in 2026 and is predicted to hit around USD 7.74 billion by 2035, growing at a CAGR of 9.90%.
September 2026
The monoclonal antibodies market size totalled USD 321.83 billion in 2026, with major monoclonal antibodies market players including johnson & johnson, merck, AbbVie, amgen, Pfizer inc, norvatis ag.
September 2026
The antibody production market size was estimated at USD 31.71 billion in 2025 and it is expected to surpass USD 93.76 billion by 2035 with a CAGR of 12.83%.
September 2026
The global veterinary monoclonal antibodies market size is estimated to hit around USD 5.62 billion by 2035 increasing from USD 1.96 billion in 2026, with a CAGR of 12.44%.
September 2026
The global biosimilars market size is exhibited at USD 47.36 billion in 2026 and is projected to hit around USD 191.29 billion by 2035, growing at a solid CAGR of 16.84%.
September 2026
The global antibody discovery market size was estimated at USD 9.92 billion in 2026 and is projected to hit around USD 22.28 billion by 2035 with a CAGR of 9.42%.
September 2026
The global biologics and biosimilars market size is estimated to hit around USD 2,426.85 billion by 2035 increasing from USD 700.76 billion in 2026, with a CAGR of 14.80%.
September 2026
The global custom antibody market reached USD 232.14 billion in 2026, featuring leading custom antibody companies such as GenScript, LifeSpan BioSciences, Inc, Labcorp Drug Development, Abmart.
August 2026
The global antibody drug conjugates market size is projected to hit around USD 34.80 billion by 2035 from USD 12.69 billion in 2025 with a soild CAGR of 10.61%.
June 2026
The global neutralizing antibody market size is estimated to hit around USD 574.88 billion by 2035 increasing from USD 274.17 billion in 2026, with a CAGR of 8.59%.
June 2026
The global immunology biosimilars market size was estimated at USD 13.24 billion in 2026 and is expected to hit around USD 56.39 billion by 2035, growing at a CAGR of 17.51%.
June 2026
The global psoriasis biosimilars market size is evaluated at USD 10.46 billion in 2025 and is projected to attain around USD 29.78 billion by 2035, with a CAGR of 11.03%.
April 2026
The global cancer monoclonal antibodies market size reached USD 125.10 billion in 2025 and is predicted to hit around USD 658.07 billion by 2035, with a solid CAGR of 18.06%.
January 2026
The global bispecific antibody therapeutics contract manufacturing market size was evaluated at USD 9.82 billion in 2025 and is predicted to hit around USD 218.92 billion by 2035, growing at a CAGR of 36.4%.
January 2026
The global next-generation bispecific antibody market size was evaluated at USD 9.53 billion in 2025 and is predicted to hit around USD 52.08 billion by 2035, growing at a CAGR of 18.51%.
August 2025
The global antibody ELISA kits for tropical infectious disease market size was valued at USD 2.39 billion in 2024 and is expected to hit around USD 4.41 billion by 2034, growing at a CAGR of 6.32%.
August 2025
The global anti-thyroid peroxidase antibody test kit market size was valued at USD 150.07 million in 2024 and is expected to hit around USD 341.19 million by 2034, growing at a CAGR of 8.56%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com